Search

everythinglearnresearchcommunity

for

Search:↓

As of 1994, treatments for liver cancer had not significantly improved patient survival.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

The link between anabolic agents and colorectal cancer risk is unclear.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

PRP therapy's success varies and depends on PRP quality and patient condition, with athletes benefiting more.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Medicinal plants have potential as alternative cancer treatments due to their ability to target and kill cancer cells.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Aromatase inhibitors cause male pattern hair loss in women.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Testosterone therapy can improve hormone levels and quality of life in men with morphine-induced hormone issues.

Nonionic liposomes are the best for delivering genes to skin cells.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Trastuzumab may cause tufted hair folliculitis as a side effect.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Modified PRP therapy successfully treated severe alopecia unresponsive to traditional methods.